XSTO
AMBEA
Market cap1.20bUSD
Jul 09, Last price
144.60SEK
1D
0.14%
1Q
5.55%
IPO
94.67%
Name
Ambea AB (publ)
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ambea AB (publ) is a Swedish-headquartered company established in 1996, which provides comprehensive health and social care services. These offerings include accommodation, personal support, educational programs, and staffing solutions, primarily catering to the elderly and individuals with disabilities across Sweden, Norway, and Denmark. The company organizes its operations into five distinct segments: Nytida, Vardaga, Stendi, Altiden, and Klara. Nytida focuses on residential care, tailored support for individuals and families, specialized schooling for children, adolescents, and adults facing disabilities or psychosocial challenges, in addition to day programs. Vardaga specializes in elderly care, encompassing nursing homes, temporary residential facilities, in-home care services, and day activities for seniors. Stendi delivers a broad spectrum of services for children, young people, and adults, including personal assistance, residential care, elderly care, and home-based support. Altiden's offerings include services for the elderly, home care, social support, and specialized disability care. Lastly, Klara provides subscription-based mobile healthcare teams and supplies temporary medical and nursing professionals.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||